Access count of this item: 1077

Files in This Item:
File Description SizeFormat 
56_215.pdf914.47 kBAdobe PDFView/Open
Title: 下部尿路症状(LUTS) を有し,慢性骨盤痛症候群(CPPS) 症状を合併する患者に対するα1 アドレナリン受容体遮断薬ナフトピジルによる臨床的有効性の検討 : 日本語版NIH-CPSI を用いた投与前後4週間の比較
Other Titles: Effects of α1 Adrenoceptor Antagonist, Naftopidil, on Non-Bacterial Chronic Pelvic Pain Syndrome in Patients with Lower Urinary Tract Syndrome: The Evaluation of Its Efficacy Using NIH-CPSI after 4-Week Treatment
Authors: 鈴木, 明  KAKEN_name
大日向, 充  KAKEN_name
藤島, 幹彦  KAKEN_name
平野, 繁  KAKEN_name
工藤, 卓次  KAKEN_name
船木, 廣英  KAKEN_name
赤坂, 俊幸  KAKEN_name
Author's alias: Suzuki, Akira
Ohinata, Mitsuru
Fujishima, Mikihiko
Hirano, Shigeru
Kudou, Takuji
Funaki, Hiroyoshi
Akasaka, Toshiyuki
Keywords: Chronic pelvic pain syndrome
Issue Date: Apr-2010
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 56
Issue: 4
Start page: 215
End page: 219
Abstract: We investigated the effect of naftopidil an α1 adrenoceptor antagonist on non-bacterial chronic pelvic pain syndrome (CPPS) in middle-aged and older male patients with lower urinary tract symptoms (LUTS). Patients who had given informed consent were treated with naftopidil (daily 50 mg), and were evaluated using the Japanese edition of NIH chronic prostatitis symptom index (NIH-CPSI) and the international prostate symptom score (IPSS) at 2 and 4 weeks after the administration. The NIH-CPSI (total score) was significantly improved by naftopidil for 4 weeks (11.5±6.0, n=62, p<0.001) as compared with the baseline (19.8±5.7). Other items of NIH-CPSI of pain, urinary symptoms, and quality of life-impact, and IPSS were also ameliorated by naftopidil as compared with the baseline (n=62, p<0.001 each). One patient had slight dizziness, but no severe adverse events were noted in any patient. It is suggested that naftopidil could be an effective and safe therapeutic option for middle-aged and older male LUTS patients with CPPS.
Rights: 許諾条件により本文は2011-05-01に公開
PubMed ID: 20448445
Appears in Collections:Vol.56 No.4

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.